GH12-008: Expanding test and treat for HIV prevention in MSM in Kisumu, Kenya
GH12-008: Expanding test and treat for HIV prevention in MSM in Kisumu, Kenya
批准号:
8729332
负责人:
Fredrick Odhiambo Otieno
金额:
$0.5万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-30 至 2017-09-29
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Men who have sex with men (MSM) in sub-Saharan Africa have 2-4 times higher HIV
prevalence than the general male population. The proportion of HIV infections attributable to
MSM in Kenya is 20%, yet MSM remain a hidden, vulnerable, and highly stigmatized
population. With the success of the HPTN 052 trial, a find, test, link and retain in care (FTLR)
model has renewed promise for HIV prevention, but is unlikely to decrease infections among
MSM unless interventions are specifically adapted to and targeted for MSM in order to reach
them. In this study, we will expand on previous work among MSM in Kisumu to find 700 men
who report having anal or oral sex with another man in the last 6 months, and test them for HIV.
We will link all HIV-positive men to PEPFAR-supported HIV care including antiretroviral
therapy (ART), and evaluate the success of a model based on PEPFAR guidance to promote
ART adherence, retention in care, and risk reduction. We will also link all HIV-negative men to
a risk reduction program including HIV testing with ongoing counseling. Outcomes of the testing
program include number of men not previously tested, number of new diagnoses, and number of
HIV-positive men needing linkage to care. For the HIV-positive men, outcomes of the
intervention component include time to linkage in care, time to staging, time to ART initiation,
retention in care, and, for those who initiate ART, self-reported measures of adherence and
virologic suppression. For the HIV-negative men, outcomes of the intervention will include
retesting rates and risk behaviors while in follow-up. For both groups, risk reduction outcomes
including reduction in number of partners and unprotected anal intercourse (UAI) will be
analyzed. This study will provide the evidence necessary to guide PEPFAR programming for
expansion of comprehensive HIV prevention among MSM in sub-Saharan Africa.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
GH12-008: Expanding test and treat for HIV prevention in MSM in Kisumu, Kenya
-
批准号:9076442
-
项目类别:
-
资助金额:$69.97万
-
财政年份:2013
-
负责人:Fredrick Odhiambo Otieno
-
依托单位:
国内基金
海外基金
登录
查看更多内容
气单胞菌突变株对噬菌体phiA008产生抗性的机制研究
-
批准号:2023J01143
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2023
-
负责人:林茂
-
依托单位:
睾酮上调的tRF-Ala-AGC-008与YB1共同调控GAS6表达保护TNF-α诱导的血管内皮细胞衰老及延缓AS进程的机制研究
-
批准号:82260085
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:赵锐
-
依托单位:
tRF-His-008在肾透明细胞癌侵袭转移中的作用及其上下游分子机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:54.7万元
-
批准年份:2021
-
负责人:李恭会
-
依托单位:
tRNA衍生片段tRF-Ser-TGA-008调控PREX1表达抑制皮肤黑素瘤侵袭转移的作用及机制研究
-
批准号:82002910
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:倪娜娜
-
依托单位:
喉癌细胞焦亡调控新分子tRF-Val-CAC-008在其早期无创诊断中的作用及机制研究
-
批准号:LQ21H130001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:邓红霞
-
依托单位:
长链非编码RNA uc008ppm.1作为抗心肌纤维化治疗靶点的潜能和调控机理研究
-
批准号:81970223
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:雷伟
-
依托单位:
新型FGFR候选新药GF008个性化特征研究——GF008获得性耐药机制探讨
-
批准号:81773762
-
项目类别:面上项目
-
资助金额:48.0万元
-
批准年份:2017
-
负责人:艾菁
-
依托单位:
LncRNA-uc008xkb.1调控PGC-1α介导肝脏缺血再灌注损伤的机制研究
-
批准号:81470876
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:麻勇
-
依托单位:
水稻防卫基因BpHi008A启动子中褐飞虱应答区域及应答核心元件的确定
-
批准号:30570137
-
项目类别:面上项目
-
资助金额:25.0万元
-
批准年份:2005
-
负责人:袁红雨
-
依托单位:
通过组合生物合成特异性积累克念菌素/抗生素FR-008的活性组分
-
批准号:30400004
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2004
-
负责人:白林泉
-
依托单位: